Founded in 1987 and headquartered in Melbourne, Australia, Vision has operations in Australia, the United States and the United Kingdom. Vision is a manufacturer and marketer of automated instruments including the Peloris™ rapid tissue processor and the Bond™-maX advanced staining system, as well as Novocastra™ antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases.
Danaher Corporation is a leading manufacturer of Professional Instrumentation, Industrial Technologies, and Tools and Components (http://www.danaher.com/).
Statements in this release that are not strictly historical may be "forward-looking" statements. These forward-looking statements include statements about Danaher's acquisition of shares in connection with the compulsory acquisition process and any other statements about future expectations, beliefs, goals, plans or prospects. There are a number of important risks and uncertainties that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These risks and uncertainties include, among other things, the risks and uncertainties set forth in Danaher's filings with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date of this release and Danaher does not intend to update any forward-looking statement.
SOURCE: Danaher Corporation
CONTACT: Andy Wilson, Vice President, Investor Relations, of Danaher
Corporation, +1-202-828-0850, or Fax: +1-202-828-0860
Web site: http://www.danaher.com/